Study reveals poor immunity against SARS-CoV-2 BQ.1.1 and XBB mutants in Norway

Science Instruments in laboratory room. Science Research Concept.

Researchers conducted a seroprevalence study in the general population of Norway, evaluating immunity against multiple subvariants of SARS-CoV-2 Omicron, including XBB and BQ.1.1 mutants.

What was the prevalence of respiratory syncytial virus between August and December 2022?

Previous article

Consumers care more about taste than gene editing for table grapes

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News